Lucid Diagnostics Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Lucid Diagnostics Inc. now
Current reporting with the operating signal separated from the noise.
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results
The story matters when it changes Lucid Diagnostics Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call Transcript
Investors are testing whether Lucid Diagnostics Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call Transcript
The story matters when it changes Lucid Diagnostics Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest LUCD filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Lucid Diagnostics Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
Second quarter
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →